Capricor Therapeutics
CAPR
#7992
Rank
NZ$0.50 B
Marketcap
NZ$10.98
Share price
-4.36%
Change (1 day)
-57.33%
Change (1 year)

Capricor Therapeutics (CAPR) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : NZ$73.52 Million

According to Capricor Therapeutics 's latest financial reports the company's total liabilities are NZ$73.52 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Capricor Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$44.36 M-22.36%
2023-12-31NZ$57.13 M-5.31%
2022-12-31NZ$60.33 M313.69%
2021-12-31NZ$14.58 M63.95%
2020-12-31NZ$8.89 M40.18%
2019-12-31NZ$6.34 M-8.08%
2018-12-31NZ$6.9 M-2.84%
2017-12-31NZ$7.1 M-78.36%
2016-12-31NZ$32.84 M31.44%
2015-12-31NZ$24.98 M-1.53%
2014-12-31NZ$25.37 M243.36%
2013-12-31NZ$7.38 M1048.84%
2012-12-31NZ$0.64 M-7.28%
2011-12-31NZ$0.69 M-49.94%
2010-12-31NZ$1.38 M57.87%
2009-12-31NZ$0.87 M-61.75%
2008-12-31NZ$2.29 M-6.96%
2007-12-31NZ$2.46 M1189.32%
2006-12-31NZ$0.19 M67.85%
2005-12-31NZ$0.11 M36.92%
2004-12-31NZ$0.08 M29.56%
2003-12-31NZ$0.06 M36.94%
2002-12-31NZ$0.04 M112.11%
2001-12-31NZ$0.02 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Cytokinetics
CYTK
NZ$3.38 B 4,498.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
NZ$17.46 M-76.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$196.08 B 266,605.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$2.17 B 2,864.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ$86.48 M 17.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
NZ$4.49 M-93.89%๐Ÿ‡บ๐Ÿ‡ธ USA